切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2016, Vol. 12 ›› Issue (03) : 321 -325. doi: 10.3877/cma.j.issn.1673-5250.2016.03.013

所属专题: 文献

论著

不同中医辨证分型过敏性紫癜患儿的血清白三烯B4及白细胞介素6含量变化
杨昆1,(), 卢野2, 陈燕子2, 李叶雨2, 王飞2   
  1. 1. 610072 成都中医药大学附属医院儿科
    2. 610075 成都中医药大学
  • 收稿日期:2016-03-02 修回日期:2016-04-03 出版日期:2016-06-01
  • 通信作者: 杨昆

Changes of serum leukotriene B4 and interleukin-6 contents in Henoch-Schonlein purpura children with different traditional Chinese medicine syndrome differentiations

Kun Yang1,(), Ye Lu2, Yanzi Chen2, Yeyu Li2, Fei Wang2   

  1. 1. Department of Pediatrics, Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, Sichuan Province, China
    2. Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China
  • Received:2016-03-02 Revised:2016-04-03 Published:2016-06-01
  • Corresponding author: Kun Yang
  • About author:
    Corresponding author: Yang Kun, Email:
引用本文:

杨昆, 卢野, 陈燕子, 李叶雨, 王飞. 不同中医辨证分型过敏性紫癜患儿的血清白三烯B4及白细胞介素6含量变化[J/OL]. 中华妇幼临床医学杂志(电子版), 2016, 12(03): 321-325.

Kun Yang, Ye Lu, Yanzi Chen, Yeyu Li, Fei Wang. Changes of serum leukotriene B4 and interleukin-6 contents in Henoch-Schonlein purpura children with different traditional Chinese medicine syndrome differentiations[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2016, 12(03): 321-325.

目的

探讨过敏性紫癜(HSP)患儿中医辨证施治治疗前、后血清白三烯B4(LTB-4)及白细胞介素6(IL-6)含量变化及其临床意义。

方法

选择2012年1月至2014年12月,于成都中医药大学附属医院儿科门诊确诊并治疗的70例HSP患儿为研究对象,纳入HSP组,其中中医辨证分型为血热妄行型为45例、气不摄血型为25例。将同期于本院门诊体检的20例健康儿童纳入对照组。采用酶联免疫吸附测定(ELISA)法,检测两组儿童血清LTB-4及IL-6含量。将HSP组患儿治疗前与治疗后的血清LTB-4及IL-6含量进行统计学比较,并分别与对照组儿童进行统计学比较;同时比较2种中医辨证分型HSP患儿治疗后血清LTB-4、IL-6含量下降值差异及病情反复率、肾脏损害率差异。两组儿童年龄及性别构成比比较,差异无统计学意义(P>0.05)。本研究遵循的程序符合成都中医药大学附属医院伦理审查委员会制定的伦理学标准,得到该委员会批准,征得受试对象监护人知情同意,并与之签署临床研究知情同意书。

结果

①HSP组患儿治疗前LTB-4及IL-6含量[(114.7±6.3) ng/L、(286.9±64.1) ng/L],均较对照组[(18.5±0.5) ng/L、(35.4±3.5) ng/L]或HSP组患儿治疗后[(18.2±1.9) ng/L、(34.9±2.3) ng/L]高,且差异均有统计学意义(t=-6.794、-6.794,P<0.05;t=-7.271、-7.271,P<0.05)。②治疗后血热妄行型HSP患儿血清LTB-4、IL-6含量下降值[(100.7±4.0) ng/L、(288.5±43.3) ng/L],均较气不摄血型含量下降值[(94.2±6.3) ng/L、(186.0±35.5) ng/L]多,且差异有统计学意义(t=5.23、-10.10,P<0.05);而气不摄血型HSP患儿病情反复率及肾脏损害率(40.0%、20.0%),均较血热妄行型(15.6%、2.2%)者高,且差异有统计学意义(χ2=5.22、6.48,P<0.05)。

结论

中医辨证施治对HSP患儿血清LTB-4及IL-6含量有调节作用。气不摄血型HSP患儿病情易反复,并且容易发生肾脏损害。

Objective

To observe the contents changes and the clinical significance of both serum leukotriene B4(LTB-4) and interleukin 6(IL-6) of children with Henoch-Schonlein purpura(HSP) after treatment determine based on traditional Chinese medicine(TCM) differentiation of symptoms and signs.

Methods

From January 2012 to December 2014, a total of 70 HSP children who were diagnosed and treated in pediatric out-patient department in Teaching Hospital of Chengdu University of Traditional Chinese Medicine, were chosen as study objects and including in HSP group, while 45 of them were diagnosed as TCM syndrome type of"hemopyretic bleeding", and 25 of them were diagnosed as"qi falling to control blood". Meanwhile, another 20 healthy children who were taken health examinations in out-patient department at the same time in the same hospital were including in control group.Enzyme-linked immunosorbent assay(ELISA) method was used to detect the contents of both serum LTB-4 and IL-6 in two groups. Compared differences of serum contents of LTB-4 and IL-6 of following: between before treatment and after treatment in HSP group, between HSP group before treatment or HSP group after treatment and control group, respectively; also compared the descending values of serum contents of LTB-4 and IL-6 after treatments, disease repeated rates and kidney injury rates between two TCM syndrome types of HSP children by statistical methods. There were no significant differences between two groups in age and gander constituent ratios(P>0.05). The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Teaching Hospital of Chengdu University of Traditional Chinese Medicine. Informed consent was obtained from the parents of each participant.

Results

①Contents of serum LTB-4 and IL-6 in HSP group before treatment[(114.7±6.3) ng/L, (286.9±64.1) ng/L] were higher than those of control group[(18.5±0.5) ng/L, (35.4±3.5) ng/L], or those of HSP group after treatment[(18.2±1.9) ng/L, (34.9±2.3) ng/L], and all the differences above were statistically significant (t=-6.794, -6.794; P<0.05.t=-7.271, -7.271; P<0.05). ②Descending values of contents of serum LTB-4 and IL-6 after treatments of"hemopyretic bleeding"HSP children[(100.7±4.0) ng/L, (288.5±43.3) ng/L] were more than those of"qi falling to control blood"HSP children [(94.2±6.3) ng/L, (186.0±35.5) ng/L], and the differences were statistically significant(t=5.23, -10.10; P<0.05). But, the disease repeated rates and kidney injury rates of"qi falling to control blood"HSP children(40.0%, 20.0%) were higher than those of"hemopyretic bleeding"HSP children(15.6%, 2.2%), and the differences were statistically significant (χ2=5.22, 6.48; P<0.05).

Conclusions

Determine treatment based on TCM differentiation of symptoms and signs has modifying effects on contents of serum LTB-4 and IL-6 in children with HSP.There is more possibility for"qi falling to control blood"HSP children to get disease repeat and kidney injury.

表1 两组儿童及HSP组患儿治疗前、后血清LTB-4、IL-6含量比较(ng/L,±s)
表2 HSP组2种中医辨证分型HSP患儿治疗后血清LTB-4、IL-6含量下降值及HSP病情反复率与肾脏损害率比较(ng/L,±s)
1
唐雪梅.过敏性紫癜病因及免疫发病机制[J].中华实用儿科临床杂志,2012,27(21):1634-1636.
2
温柠如,张君.过敏性紫癜病因及发病机制的研究进展[J].实用中医内科杂志,2011,25(7):45-46.
3
郑珊,曹霞,何素容.过敏性紫癜的中医辨证研究进展[J].中国中医急症,2013,22(11):1930-1932.
4
张霞,徐向宇,于文静,等.1 228例过敏性紫癜儿童中医证候分布规律研究[J].中医杂志,2013,54(18):1577-1579.
5
张健鸿,兰志建,杨世隆,等.中西医结合疗法治疗小儿过敏性紫癜的血清免疫学研究[J].免疫学杂志,2014,30(1):89-92.
6
袁斌,孙轶秋,樊忠民,等.凉血化淤通络法治疗小儿过敏性紫癜肾炎临床疗效及病理类型关系[J].中华中医药杂志,2011,26(3):614-616.
7
中华中医药学会.中医儿科常见病诊疗指南[M].北京:中国中医药出版社,2012:175-179.
8
胡亚美,江载芳.诸福棠实用儿科学.7版[M].北京:人民卫生出版社,2002:680-690.
9
Reid-Adam J.Henoch-Schonlein Purpura[J].Pediatr Rev, 2014, 35(10):447-449.
10
Bluman J, Goldman RD.Henoch-Schönlein purpura in children: limited benefit of corticosteroids[J].Can Fam Physician, 2014, 60(11):1007-1010.
11
Callen JP.Henoch-Schönlein purpura is linked to HLA-DRB genetic aberrations[J].J Watch, 2015: 36993.
12
Fatima A, Gibson DP. Pneumatosis intestinalis associated with Henoch-Schönlein purpura[J].Pediatrics, 2014, 134(3):e880-e883.
13
Callen JP.Henoch Schönlein purpura-observations from a large cohort in northwest Spain[J].J Watch, 2014:34653.
14
张庆群,陈秀霞,付元,等.过敏性紫癜患儿外周血单核细胞表面TLR2,4,6的表达及其与辅助性T细胞17的相关性分析[J].中华妇幼临床医学杂志:电子版,2014,10(5):623-629.
15
刘文东,于凌翔,薛爱红,等.过敏性紫癜血清TNF-α、IL-4和IL-6的变化及临床意义[J].中国儿童保健杂志,2011,19(1):77-80.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[4] 王雅楠, 刘丹, 曹正浓, 贾慧敏. 儿童迟发性先天性膈疝患儿的临床诊治特点分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 410-419.
[5] 陈桂华, 钟小玲, 谢雨, 王慧, 谢江, 杨涛毅. 合并肝脏疾病特殊健康状态儿童疫苗预防接种及时性临床分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 431-439.
[6] 雷丽莉, 于晓峰, 王媛媛, 徐迎军. 人鼻病毒感染喘息急性发作儿童外周血NLRP3和TLR4水平及临床意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 440-445.
[7] 顾盼盼, 董传莉, 宋梦瑶, 瞿色华, 杨小迪, 周瑞. 不完全性川崎病患儿临床特征及冠状动脉损害情况分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 446-451.
[8] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[9] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[10] 曾纪晓, 徐晓钢, 王欣星, 刘斐, 兰梦龙, 陶波圆, 梁子建, 叶志华, 罗媛圆. 达芬奇机器人辅助Swenson-like巨结肠根治术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 239-243.
[11] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[12] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[13] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要